Biotech, Pharmaceutical & Medical Equipment Auctions & Asset Sales

Ongoing modernization within biotech, pharmaceutical, and medical operations results in surplus laboratory, production, and facility assets as research priorities shift, products reach end of life, and manufacturing footprints evolve. Heritage Global Partners has a long track record supporting asset dispositions within this sector for research laboratories, clinical operations, and regulated manufacturing facilities, including surplus laboratory equipment sales and complete facility liquidations, frequently spanning multiple operational sites.

Heritage Global Partners maintains exclusive master service agreements with Pfizer and Amgen for the disposition of surplus biotech and pharmaceutical assets. Sales in this category originate from research and development transitions, facility consolidations, and corporate restructuring, supporting buyers active in regulated scientific and healthcare environments.

Typical Assets Sold

Current Auctions

Past Auctions

Qpex
Global Online Auction Featuring Late Model Lab Equipment Formerly Of A Resistance-Focused Infectious Disease Company! San Diego, CA.

Starting: Nov 21st, 2022 7:00am PDT

Ending: Nov 22nd, 2022 9:00am PDT

Immediately Accepting Bids
PSS (Pre 2023)
Global Online Auction Featuring Quality Biotech and Pharmaceutical Lab Equipment From Multiple Global Sellers! Multiple Locations, US.

Starting: Nov 14th, 2022 7:00am PDT

Ending: Nov 15th, 2022 8:00am PDT

Immediately Accepting Bids
Zymergen
Global Online Auction #2 Featuring Late Model Lab Equipment Formerly of Zymergen & Other Leading Labs! Woonsocket, RI.

Starting: Nov 7th, 2022 6:00am EDT

Ending: Nov 9th, 2022 7:00am EDT

Immediately Accepting Bids
SummerBio
Sale #2: Online Auction Featuring State of the Art New & Like New Lab Equipment From Covid-19 Testing Facility! Menlo Park, CA.

Starting: Oct 31st, 2022 7:00am PDT

Ending: Nov 1st, 2022 9:00am PDT

Immediately Accepting Bids
PSS (Pre 2023)
Global Online Auction Featuring Quality Biotech and Pharmaceutical Lab Equipment From Multiple Global Sellers! Multiple Locations, US.

Starting: Oct 20th, 2022 7:00am PDT

Ending: Oct 21st, 2022 9:00am PDT

Immediately Accepting Bids
Zymergen
Global Online Auction Featuring Late Model Lab Equipment Formerly of Zymergen! Woonsocket, RI.

Starting: Oct 17th, 2022 6:00am EDT

Ending: Oct 19th, 2022 10:00am EDT

Immediately Accepting Bids
BP Lubricants
Global Online Auction Featuring Lab Testing & Analytical Equipment Surplus To BP Lubricants! Rolling Meadows, IL.

Starting: Sep 16th, 2022 7:00am CDT

Ending: Oct 13th, 2022 10:00am CDT

Immediately Accepting Bids
Nektar
Global Online Auction Featuring Late Model State of the Art Lab Assets From Nektar Therapeutics. Hayward, CA.

Starting: Oct 11th, 2022 7:00am PDT

Ending: Oct 12th, 2022 10:00am PDT

Immediately Accepting Bids
SummerBio
Phenomenal Offering! Online Auction Featuring State of the Art New & Like New Lab Equipment From Covid-19 Testing Facility! Menlo Park, CA.

Starting: Sep 20th, 2022 7:00am PDT

Ending: Sep 21st, 2022 9:00am PDT

Immediately Accepting Bids
PSS (Pre 2023)
Global Online Auction Featuring Quality Biotech and Pharmaceutical Lab Equipment From Multiple Global Sellers! Multiple Locations, US.

Starting: Sep 15th, 2022 7:00am PDT

Ending: Sep 16th, 2022 8:00am PDT

Immediately Accepting Bids

Managing surplus lab or regulated manufacturing assets?

Buyer FAQs

Many cleanroom components, HVAC systems, and lab assets can be reused in non-GMP or pilot-scale applications with modification.
Buyers should evaluate service history, manufacturer support status, software compatibility, and calibration requirements.
Validation documentation may be available when provided by the seller and is disclosed within the listing of assets for sale.

Seller FAQs

Sales are often structured to align with internal QA, EHS, and compliance teams prior to equipment release.
Yes. Asset-only dispositions can be structured without referencing product names or research outcomes.

Sales are often driven by pipeline changes, site consolidations, regulatory strategy shifts, or the retirement of specific research or production programs.